Urinary tract infections (UTIs) belong to the most common community-acquired and
nosocomial infections. A main etiological factor of UTIs is uropathogenic Escherichia coli …

Multidrug-resistant (MDR) Klebsiella pneumoniae represents an increasing threat to human
health, causing difficult-to-treat infections with a high mortality rate. Since colistin is one of …

Fosfomycin is a decades-old antibiotic which is being revisited because of its perceived
activity against many extensively drug-resistant Gram-negative pathogens. FosA proteins …

Fosfomycin was discovered over four decades ago, yet has drawn renewed interest as an
agent active against a range of multidrug-resistant (MDR) and extensively drug-resistant …

Urinary tract infections (UTIs) are among the most commonly treated bacterial infections.
Over the past decade, antimicrobial resistance has become an increasingly common factor …

Abstract Trimethoprim (TMP)-sulfamethoxazole (SMX) is a widely used synergistic
antimicrobial combination to treat a variety of bacterial and certain fungal infections. These …

Urinary tract infections (UTI) are one of the most common indications for antibiotic
prescriptions in the outpatient setting. Given rising rates of antibiotic resistance among …

Antimicrobial peptides may be alternatives to traditional antibiotics with reduced bacterial
resistance. The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2 …

There are challenges regarding increased global rates of microbial resistance and the
emergence of new mechanisms that result in microorganisms becoming resistant to …

Objectives Fosfomycin susceptibility testing is complicated and prone to error. Before using
fosfomycin widely in patients with serious infections, acquisition of WT distribution data and …